Skip to content

AMN Healthcare AMN Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin27.6%-0.7pp28.3%-1.0pp29.4%-0.5pp29.8%-0.3pp30.1%-0.7pp
Net margin-0.9%+2.6pp-3.5%+6.6pp-10.1%+0.6pp-10.8%-5.0pp-5.8%-0.9pp
EBITDA margin5.9%+2.2pp3.7%+7.6pp-3.9%+0.7pp-4.6%-6.0pp1.4%-1.0pp
Free cash flow margin20.7%+12.1pp8.6%+0.4pp8.2%-1.0pp9.2%+0.1pp9.1%+1.1pp
Returns
Return on equity-4.5%+9.6pp-14.2%+21.7pp-35.9%+4.2pp-40.1%-19.0pp-21.1%-2.0pp
Return on assets-1.3%+2.9pp-4.2%+7.2pp-11.5%+0.5pp-12%-5.7pp-6.3%-0.8pp
Return on invested capital4.1%+8.0pp-3.9%+13.2pp-17.1%+2.0pp-19%-10.7pp-8.3%-1.7pp
Efficiency
Asset turnover1.4×+0.2×1.2×+0.1×1.1×0.0×1.1×0.0×1.1×0.0×
Liquidity
Current ratio1.1×+0.1×0.9×-0.1×1.1×+0.1×-0.1×1.1×0.0×
Quick ratio1.1×+0.1×0.9×-0.1×1.1×+0.1×-0.1×1.1×0.0×
Cash ratio0.6×+0.5×0.1×0.0×0.2×0.0×0.1×0.0×0.2×0.0×
Leverage
Debt-to-equity1.1×-0.1×1.2×-0.2×1.4×-0.1×1.5×+0.2×1.2×0.0×
Debt-to-assets0.3×-0.1×0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Net debt / EBITDA0.9×-6.1×20.3×+9.1×
Interest coverage1.2×+2.4×-1.2×+3.5×-4.7×0.0×-4.8×-2.8×-2×-0.5×
Per Share
Book value per share$18.22+9.3%$16.67+0.1%$16.65+5.3%$15.82-15.3%$18.66+0.9%
Valuation
Market capitalization$1.23B+49.8%$605.4M-18.4%$741.96M-10.5%$828.95M-11.3%$934.39M+2.6%
Enterprise value$1.41B-11.9%$1.32B-14.7%$1.54B-6.0%$1.64B-4.9%$1.73B+1.0%
Price / sales0.4×+0.1×0.2×-0.1×0.3×0.0×0.3×0.0×0.3×0.0×
Price / book1.8×+0.6×0.9×-0.2×1.2×-0.2×1.4×+0.1×1.3×0.0×
EV / EBITDA7.1×-34.6×13×44.3×+20.2×
EV / sales0.4×-0.2×0.5×-0.1×0.6×0.0×0.6×0.0×0.6×0.0×
Free cash flow yield56.3%+25.4pp38.6%+8.6pp30%-0.8pp30.8%+3.1pp27.7%+1.4pp
Earnings yield-2.6%+17.2pp-15.8%+21.3pp-37.1%-1.2pp-35.9%-18.2pp-17.7%-1.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are AMN Healthcare's profit margins?
AMN Healthcare (AMN) runs a 27.6% gross margin and a -9.8% operating margin, with a -0.9% net margin.
Where do AMN Healthcare's ratios come from?
Every ratio is computed from AMN Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.